Marked Chart Marked Chart Closed

The Marked Chart Wire · Business

Viking Therapeutics

Viking Therapeutics misses third quarter earnings estimates

Viking Therapeutics reported a loss of $1.55 per share for the third quarter, missing the expected loss of $1.05. The company's actual results were 47.62 percent worse than analyst projections.

Illustration for the Business desk

Learn the basics

New to this? Read: Reading a stock chart

More Business news

Illustration for the Business desk

HotAmazon Earnings

Amazon shares drop after Q3 earnings miss expectations

Amazon shares fell 5 percent after hours as Q3 revenue of $201.9 billion and holiday guidance disappointed investors. AWS revenue grew 39 percent to $46 billion, but quarterly capital expenditures reached $75.8 billion.

AMZN-4.2%

Fast headlines, summarized. Not verified and not advice. Check the full story before you act.